Document Type : Original Article
Authors
1 PhD in Reproductive Health, Assistant Professor, Mother and Child Care Research Center, Faculty of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran
2 PhD in Reproductive Health, Assistant Professor, Department of Midwifery, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
3 PhD in Nursing, Full Professor, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Introduction: Regular cervical cancer screening is an effective strategy to reduce the incidence and mortality rate of this disease. Therefore, the present study aimed to explain facilitators and barriers to performing regular Pap smear tests in Iranian women.
Methods: This qualitative study was performed in 2017 in medical centers in Hamadan. The participants in this study were 23 women and 8 health care workers who were selected through purposive sampling. The inclusion criteria were the willingness to participate in the study and having the ability to communicate properly. The data were collected using in-depth semi-structured interviews and analyzed using the qualitative content analysis method with MAXQDA10 software.
Results: Three main concepts were recognized as facilitators and barriers to regular Pap smear testing: (1) Belief vs. disbelief in the possibility of cancer control and treatment, (2) Priority vs. non-priority of health in life, and (3) Ability vs. inability to overcome the challenges ahead.
Conclusion: Given the results of the study, it is necessary to establish policies to increase people's sensitivity to testing and the dominance of screening culture in society. Health officials also need to support training programs to promote women's understanding of the importance and impact of early diagnosis in controlling and treating cervical cancer and to develop and implement programs to reduce or eliminate financial, time, and emotional barriers.
Keywords
2. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev. 2017; 26(4):444-457. doi: 10.1158/1055-9965.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. International Agency for Research on Cancer. [cited 2018]. Available from URL: https://publications.iarc.fr/Databases /Iarc-Cancerbases/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-
Regular Cervical Cancer Screening for… Refaei et al
Journal of Qualitative Research in Health Sciences 2020; 9(2):155-165 163
And-Prevalence-Worldwide-In-2012-V1.0-2012.
4. Iran Ministry of Health. Instructions for providing educational services and prevention and control non-transmissible diseases in the primary health care system: Iran ministry of health. 2016. [updated 2016 December 6]. Available from: http://old.ncii.ir/content0383.html?pid=41.
5. Izycki D, Wozniak K, Izycka N. Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective. Prz Menopauzalny. 2016; 15(2):112-116. doi:10.5114/pm.2016.61194.
6. Yaghoobzadeh A, Soleimani MA, Bahrami N, Hatef Matbue Y, Padash Amleshi B. Predictors of sexual function in gynecologic cancer patients. Avicenna Journal of Nursing and Midwifery Care. 2018; 26(2):63-71. doi: 10.30699/sjhnmf.26.2.63.
7. Kadam YR, Quraishi SR, Dhoble RV, Sawant MR, Gore AD. Barriers for early detection of cancer amongst urban Indian women: a cross-sectional study. Iran J Cancer Prev. 2016; 9(1): e3900. doi: 10.17795/ijcp.3900.
8. Rerucha CM, Caro RJ, Wheeler VL. Cervical cancer screening. Am Fam Physician. 2018; 97(7):441-448. 9. Screening and Prevention Editorial Board. PDQ Cervical cancer screening. Bethesda, MD: National Cancer Institute. 2020. [Updated 2020 August 12]. Available from: http://www.cancer. gov/cancertopics/pdq/screening/cervical/HealthProfessional/page1.
10. Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge
regarding cervical cancer, Pap smear screening, and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015; 15(1):37-44. doi: 10.1186/s12905-015-0193-2.
11. Kasting ML, Wilson S, Zollinger TW, Dixon BE, Stupiansky NW, Zimet GD. Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses. Prev Med Rep. 2017; 5:169-174. doi: 10.1016/j.pmedr.2016.12.013.
12. Mohebi S, Sharifirad G, Gharlipour Z, Kamran A. The study of pap smear conduction and its related factors based on health belief model in women referring to health care centers in Qom during 2014. J Educ Community Health. 2016; 2(4):25-33. doi: 10.21859/jech-02044.
13. Sharifi M, Mohammadi Z, Makvandi Z, Rostami P, Moradi A. Assessment of cervical Cancer Screening and its Barriers in 18-50 Year Old Women Referring to Asad Abad Comprehensive Health Centers. PSJ. 2018; 16(2):35-45. doi: 10.21859/psj.16.2.35.
14. Parsa P, Karami M, Shobeiri F, Sharifi F. The effect of group counseling on cervical cancer screening knowledge and practice among rural women in Kaboudarahang city, Hamadan. The J Urmia Nurs Midwifery Fac. 2017; 14(10):875-884.
15. Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: A systematic review. Asian Pac J Cancer Prev. 2017; 18(7):1751-1763. doi: 10.22034/APJCP.2017.18.7.1751.
Regular Cervical Cancer Screening for… Refaei et al
164 Journal of Qualitative Research in Health Sciences 2020; 9(2):155-165
16. Jalilian F, Emdadi S. Factors related to regular undergoing pap-smear test: application of the theory of planned behavior. J Res Health Sci. 2011; 11(2):103-108.
17. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures, and measures to achieve trustworthiness. Nurse Educ Today. 2004; 24(2):105-112. doi: 10.1016/j.nedt.2003.10.001.
18. Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Education for information. 2004; 22(2):63-75.
19. Perng P, Perng W, Ngoma T, Kahesa C, Mwaiselage J, Merajver SD, et al. Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania. Int J Gynecol Obstet. 2013; 123(3):221-225. doi: 10.1016/j.ijgo.2013.05.026.
20. Scott SA. Knowledge and anxiety as barriers to cervical cancer screening attendance. Cleveland State University, Cleveland; 2015.
21. Tay K, Tay SK, Tesalona KC, Rashid NM, Tai E, Najib SJ. Factors affecting the uptake of cervical cancer screening among nurses in Singapore. Int J Gynaecol Obstet. 2015; 130(3):230-234. doi: 10.1016/j.ijgo.2015.03.037.
22. Martínez-Donate A, Vera LM, Zhang X, Vedro R, Angulo R, Atkinson T. Prevalence and correlates of breast and cervical cancer screening among a Midwest community sample of low-acculturated Latinas. J Health Care Poor Underserved. 2013; 24(4):1717-1738. doi: 10.1353/hpu.2013.0165.
23. Padela AI, Peek M, Johnson-Agbakwu
CE, Hosseinian Z, Curlin F. Associations between religion-related factors and cervical cancer screening among Muslims in greater Chicago. J Low Genit Tract Dis. 2014; 18(4):326-332. doi: 10.1097/LGT.0000000000000026.
24. William M, Kuffour G, Ekuadzi E, Yeboah M, ElDuah M, Tuffour P. Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed-methods approach. Afr Health Sci. 2013; 13(4):1054-1061. doi: 10.4314/ahs.v13i4.28.
25. Hasahya OT, Berggren V, Sematimba D, Nabirye RC, Kumakech E. Beliefs, perceptions and health-seeking behaviors in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign. Glob Health Action. 2016; 9: 1-9. doi: 10.3402/gha.v9.29336.
26. Fallahi A, Nemat Shahrbabaki B, Hashemian M, Ahmadi Kahanali A. The needs of women referring to health care centers for doing Pap smear test. Iranian Journal of Obstetrics, Gynecology and Infertility. 2016; 19(6):1-10.
27. Olesen SC, Butterworth P, Jacomb P, Tait RJ. Personal factors influencing the use of cervical cancer screening services: epidemiological survey and linked administrative data address the limitations of previous research. BMC Health Serv Res. 2012; 12(1):34. doi: 10.1186/1472-6963-12-34.
28. Labeit A, Peinemann F, Kedir A. Cervical cancer screening service utilization in the UK. Sci Rep. 2013; 3:2362. doi: 10.1038/srep02362.
29. Refaei M, Nayeri ND, Khakbazan Z, Pakgohar M. Cervical cancer screening
Regular Cervical Cancer Screening for… Refaei et al
Journal of Qualitative Research in Health Sciences 2020; 9(2):155-165 165
in Iranian women: healthcare practitioner perceptions and views. Asian Pac J Cancer Prev. 2017; 18(2): 357–363. doi: 10.22034/APJCP.2017.18.2.357.
30. Shneyderman Y, Rutten LJF, Arheart KL, Byrne MM, Kornfeld J, Schwartz SJ. Health information seeking and cancer screening adherence rates. J Cancer Educ. 2016r; 31(1):75-83. doi: 10.1007/s13187-015-0791-6.
31. Gahremani Nasab P, Shahnazi M, Farshbaf Khalili A, Ganbari S. Factors Related to Cervical Cancer Screening among Women Referring to Health Centers in Tabriz, Iran 2012. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2014; 16(89):15-24.
32. Ersin F, Bahar Z. Barriers and facilitating factors perceived in Turkish women's behaviors towards early cervical cancer detection: a qualitative approach. Asian Pac J Cancer Prev. 2013; 14(9): 4977-9482. doi: 10.7314/apjcp.2013.14.9.4977.
33. Nolan J, Renderos TB, Hynson J, Dai X, Chow W, Christie A, et al. Barriers to Cervical Cancer Screening and Follow‐up Care among Black Women in Massachusetts. J Obstet Gynecol Neonatal Nurs. 2014; 43(5):580-588. doi:10.1111/1552-6909.12488.
34. Bayrami R, Taghipour A, Ebrahimipour H. Personal and socio-cultural barriers to cervical cancer screening in Iran, patient and provider perceptions: a qualitative study. Asian Pac J Cancer Prev. 2015; 16(9):3729-3734. doi: 10.7314/apjcp.2015.16.9.3729.
35. Akinyemiju TF. Socio-economic and health access determinants of breast andcervical cancer screening in low-
income countries: analysis of the World Health Survey. PLoS One. 2012; 7(11):e48834. doi:10.1371/journal.pone.0048834.
36. Maseko FC, Chirwa ML, Muula AS. Health systems challenges in the cervical cancer prevention program in Malawi. Global Health Action. 2015; 8(1):1-8. doi:10.3402/gha.v8.26282.
37. McCree R, Giattas MR, Sahasrabuddhe VV, Jolly PE, Martin MY, Usdan SL, et al. Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders’ Perceptions of Structural Influences on Scale-Up. Oncologist. 2015; 20(6):621-626. doi:10.1634/theoncologist.2013-0305.
38. Augusto EF, Rosa ML, Cavalcanti SM, Oliveira LH. Barriers to cervical cancer screening in women attending the Family Medical Program in Niteroi, Rio de Janeiro. Arch Gynecol Obstet. 2013; 287(1):53-58. doi:10.1007/s00404-012-2511-3.
39. Rosser JI, Hamisi S, Njoroge B, Huchko MJ. Barriers to cervical cancer screening in rural Kenya: perspectives from a provider survey. J Commun Health. 2015; 40(4):756-61. doi: 10.1007/s10900-015-9996-1.
40. Kivuti-Bitok LW, Pokhariyal GP, Abdul R, McDonnell G. An exploration of opportunities and challenges facing cervical cancer managers in Kenya. BMC Res Notes. 2013; 6(1):136. doi:10.1186/1756-0500-6-136.
41. Gan DEH, Dahlui M. Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J. 2013; 54(3):163-168. doi:10.11622/smedj.2013047
)